Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?

@article{Spiess2007SurgicallyML,
  title={Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?},
  author={Philippe Edouard Spiess and Andrew K. Lee and Joseph Erik Busby and Jennifer J. Jordan and M. Sc. Yanier Crespo Hern{\'a}ndez and Kristina Burt and P. Brunny Troncoso and Kelly Willis Merriman and Louis Pisters},
  journal={BJU international},
  year={2007},
  volume={99 2},
  pages={321-5}
}
OBJECTIVES To review our experience with the surgical management of lymph node-positive prostate cancer and to determine if there is a benefit to treating such patients with immediate rather than delayed hormonal therapy (HT). PATIENTS AND METHODS A retrospective analysis from January 1982 to January 2001 identified 100 patients treated by radical retropubic prostatectomy (RP) either alone (70, 23 later received delayed HT) or combined with adjuvant (immediate) HT (30), with the overall… CONTINUE READING